
Wexford County Council rejects call to sever ties with companies ‘involved in breaching human rights'
However, Cllr Forde's motion was rejected out of hand with the council executive stating it 'operates its procurement activities in line with all relevant legislation, regulations, guidelines and its own public procurement policy and procedures'.
'WCC is committed to the promotion of the use of environmental and social considerations in public procurement, this is further strengthened in WCC's corporate procurement plan,' it added. 'Any proposed ethical procurement policy would have to align with the EU treaty principles of transparency, equal treatment, mutual recognition, proportionality, and non-discrimination.'
After the meeting, Cllr Forde expressed his disappointment that his motion was rejected, noting that the same motion had been passed in 13 other councils across the country.
"The purpose of this initiative is to ethically advance how councils across Ireland tender and who they are affiliated to in accordance with international law obligations," he said. "This motion has already been passed by 13 councils. It is something that could have been easily achieved here in Wexford. We should be no different in this sense and we should be pushing for more.
"Efforts to introduce such a policy have been quickly dismissed as being controlled by Europe and government and because of the potential to bring legal challenges, but I don't believe that is the case."
Asking that his motion be reconsidered, Cllr Forde said the adoption of an EPP would ensure the council does not 'financially aid businesses and companies investing, practicing or complicit in human rights abuses when tendering."
"We are living in an ever-changing world and we should be holding ourselves and human rights violators to the highest ethical standards," he added.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Agriland
2 hours ago
- Agriland
Sheep trade: Another blow dealt to lamb prices this week
This week's sheep trade sees lamb prices take a hit of up to 20c/kg at some outlets after three weeks of prices remaining steady. Processors have told Agriland that additional lamb supplies coming on the European market from other EU countries are "muddying the waters" by increasing competition on price for Irish lamb in key markets. Despite what processors are saying, farm lobby groups have hit out at sheep factories, criticising them for their move to reduce prices paid to sheep farmers. This week, Kepak is quoting €7.85/kg plus a 15c/kg Quality Assurance (QA) bonus for spring lambs, leaving €8.00/kg on offer up to 21.5kg carcass-weight. This price is down 15c/kg since last Monday. The Athleague, Co. Roscommon site is quoting €4.70-€4.80/kg for cull ewes again this week. Irish Country Meats (ICM) is quoting €7.80/kg plus a 20c/kg QA bonus for spring lambs, leaving €8.00/kg on offer here this week up to 21.5kg. The ICM lamb price offer is down 20c/kg since last Monday. The Navan, Co. Meath and Camolin, Co. Wexford-based outlets are quoting €4.50/kg for cull ewes again this week. Kildare Chilling is quoting €7.90/kg plus a 10c/kg QA bonus for spring lambs up to 21.5kg carcass-weight. Ballon Meats in Co. Carlow is quoting €8.00/kg for spring lambs this week, down 10c/kg, and €5.10/kg for cull ewes, the same as last week.

The Journal
4 hours ago
- The Journal
Trump's planning 250% tariffs on pharmaceuticals - and he hasn't forgotten about Ireland
LAST UPDATE | 1 hr ago TARIFFS ON IMPORTED pharmaceuticals into the US could go as high as 250%, President Donald Trump has said. Pharmaceuticals and semiconductors will be the next industries targeted in the latest round of Trump's tariffs, he outlined today, despite the EU claiming that it had agreed a 15% tariff cap on medicines. Speaking to CNBC this morning, Trump referenced Ireland's strength in the pharmaceuticals sector, and indicated that new tariffs on imported pharmaceuticals and semiconductors will be announced soon – potentially in the coming week. He said that other countries 'make a fortune with pharmaceuticals', 'They make our pharmaceuticals in China and Ireland,' he said, adding that upcoming tariffs on imported pharmaceuticals could reach 250%. 'We'll be putting [an] initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150%, and then it's going to go to 250% because we want pharmaceuticals made in our country,' he said. Advertisement CNBC Television / YouTube '15% cap is all-inclusive' Trump and European Commission President Ursula von der Leyen agreed a deal two weeks ago to a baseline US tariff of 15% on imports from the EU. It left out some sectors, though, including pharmaceuticals. Today, the European Commission pushed back on criticism from members of the German government that von der Leyen had not secured a good deal for businesses and citizens in the EU. Similar criticism was levelled in a recent episode of The Journal 's The Explainer p odcast, when economist and TU Dublin lecturer Emma Howard said Trump successfully 'anchored' his negotiations with the EU, which saw Europe talk him down from a proposed and unrealistic 30% tariff rate. Trade spokesperson Olof Gill stood over the agreement between the Commission President and Trump, claiming the deal secured a future without further tariffs and assured that the 15% tariff ceiling on goods 'is all-inclusive'. He said that the deal allows the EU and the US to have a 'stable platform' to move towards a zero-for-zero tariff scenario, secure future trade deals with Washington and provide certainty to businesses. His comments came after he confirmed that the European Commission today waived Europe's proposed counter tariffs against the US – despite previous claims from the EU's executive that it would move forward with reciprocal measures should tariffs be imposed. Future of tariffs on pharma Uncertainty remains, however, for the pharma industry – a lucrative sector for Ireland. In April, the Trump White House initiated new investigations into the imports of pharmaceuticals under Section 232 of the Trade Expansion Act. Read Next Related Reads Q&A: What we know (and don't know) about the EU-US tariff deal 'Resorted to submission': Last-minute US tariff deal earns stinging criticism from EU leaders Are pharmaceuticals part of the EU-US tariff deal? And what's Section 232 got to do with it? The purpose of a Section 232 investigation is to determine, in short, the effect of imports on US national security and whether certain imports 'threaten to impair' national security. Its outcome will determine if placing tariffs on goods such as medicines, which the US largely imports, threatens the security of the American job market, economic growth or foreign direct investment, monetary or otherwise. Trump's plans have incited concerns overseas, as governments that expect to be hit the most try to appease him to avoid high tariff leaders are due to travel to Washington DC today for talks to try to swerve a 39% tariff due Thursday. Similarly to Ireland, pharmaceuticals represent a large majority (60%) of Swiss goods that are exported to the US. Additional reporting by AFP and Muiris Ó Cearbhaill Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal


Agriland
5 hours ago
- Agriland
Eu to Co Fund Bord Bia Beef and Lamb Promotion Campaign
The European Commission is to co-fund a Bord Bia information and promotional campaign for beef and lamb. The 'Sustainable European Beef and Lamb - Trusted Tradition, Technical Excellence' campaign will be funded to the tune of €3.46 million, with €2.77 million of that coming from the EU and some €690,000 coming from Bord Bia. The three-year campaign will promote European beef and lamb over the next three years in China, Japan and Singapore. The objectives of the programme are to develop increased awareness of the "high safety and quality standards" of EU beef and lamb as well as their attributes as natural, nutritional and sustainable products, the Department of Agriculture, Food and the Marine said. According to the department, the campaign will highlight the specific features of beef and lamb production methods within the EU and the programmes at farm and processing levels which verify their sustainability. Welcoming the co-funding decision, Minister for Agriculture, Food and the Marine Martin Heydon said: "I am delighted to see the EU recognition and financial support for this Bord Bia programme on sustainable EU beef and lamb. "This campaign will provide the marketing edge for EU beef and lamb exports to capitalise on the significant market opportunities in China, Japan and Singapore." The minister said that the campaign will ultimately expand these important markets. "The programme will reinforce Europe's ambition to be the global reference for sustainable food production and sustainable nutrition. This ambition is also reflected in Ireland's own stakeholder led strategy for the sustainable development of the agri-food sector, Food Vision 2030," Minister Heydon added. The co-funding was also welcomed by Minister of State for food promotion and new markets Noel Grealish. He said: "The programme gives Bord Bia the opportunity to continue the promotion, development and growth of EU beef and lamb in these key regions. "With current market uncertainty, the importance of on-going market diversification into these key markets cannot be understated. "Growing the presence of EU beef and lamb in China, Japan and Singapore will benefit the sector and this targeted campaign will help develop that growth, while also promoting the nutritional value and sustainability of EU beef and lamb," Minister Grealish added. Chief executive of Bord Bia Jim O'Toole said: "Promotional campaigns that have EU support give EU producers and processors immediate access to some of the top meat buyers in China, Japan and Singapore. "EU co-funded campaigns help Bord Bia to showcase quality products to buyers in these priority markets; develop new relationships between exporters, and local importers and distributors, while also strengthening the business relationships exporters have already developed with stakeholders in these countries," O'Toole added.